94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Vidthiya Jeyanathan1,2Sam Afkhami1,2Michael R. D’Agostino1,3Anna Zganiacz1,2Xueya Feng1,2Matthew S. Miller1,3Mangalakumari Jeyanathan1,2Michael R. Thompson4
Zhou Xing1,2*- 1McMaster Immunology Research Centre, M. G. DeGroote Institute for Infectious Disease Research, Hamilton, ON, Canada
- 2Department of Medicine, McMaster University, Hamilton, ON, Canada
- 3Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, ON, Canada
- 4Department of Chemical Engineering, McMaster University, Hamilton, ON, Canada
A Corrigendum on
Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
By Jeyanathan V, Afkhami S, D’Agostino MR, Zganiacz A, Feng X, Miller MS, Jeyanathan M, Thompson MR and Xing Z (2022) 13:860399. doi: 10.3389/fimmu.2022.860399
In the published article, an author name was incorrectly written as “Vidthiya Jeyananthan”. The correct spelling is “Vidthiya Jeyanathan”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: respiratory mucosal immunization, intranasal, endotracheal, biodistribution, Adenovirus-vectored vaccine, Tuberculosis, mucosal immunity, T cells
Citation: Jeyanathan V, Afkhami S, D’Agostino MR, Zganiacz A, Feng X, Miller MS, Jeyanathan M, Thompson MR and Xing Z (2023) Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes. Front. Immunol. 14:1151809. doi: 10.3389/fimmu.2023.1151809
Received: 26 January 2023; Accepted: 27 January 2023;
Published: 07 February 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Jeyanathan, Afkhami, D’Agostino, Zganiacz, Feng, Miller, Jeyanathan, Thompson and Xing. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhou Xing, eGluZ3pAbWNtYXN0ZXIuY2E=